US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist
  • 1.230
  • +0.010+0.82%
Trading Apr 24 14:24 ET
56.25MMarket Cap-3843P/E (TTM)

Icecure Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
4.67%3.23M
33.65%1.26M
-48.42%327K
22.48%937K
-4.95%710K
-25.45%3.09M
-32.15%939K
-6.90%634K
20.09%765K
-47.98%747K
Operating revenue
4.67%3.23M
33.65%1.26M
-48.42%327K
22.48%937K
-4.95%710K
-25.45%3.09M
-32.15%939K
-6.90%634K
20.09%765K
-47.98%747K
Cost of revenue
17.62%1.93M
43.51%686K
-25.21%350K
32.02%503K
24.60%390K
-15.59%1.64M
-35.49%478K
45.34%468K
-0.52%381K
-37.02%313K
Gross profit
-10.03%1.3M
23.43%569K
-113.86%-23K
13.02%434K
-26.27%320K
-34.17%1.45M
-28.30%461K
-53.76%166K
51.18%384K
-53.78%434K
Operating expense
-7.19%16.88M
-9.31%3.98M
-3.91%4.1M
-3.22%4.52M
-11.98%4.28M
52.56%18.18M
16.49%4.39M
32.97%4.27M
66.19%4.67M
127.91%4.86M
Selling and administrative expenses
-5.05%8.6M
-2.55%2.1M
-6.40%1.9M
1.08%2.44M
-12.13%2.17M
49.97%9.06M
-0.65%2.16M
22.07%2.03M
97.38%2.41M
149.49%2.47M
-Selling and marketing expense
16.55%1.21M
-68.72%-2.02M
39.15%981K
49.87%1.18M
43.91%1.08M
56.01%1.04M
-117.60%-1.2M
19.09%705K
140.37%786K
150.67%747K
-General and administrative expense
-7.85%7.39M
22.92%4.12M
-30.64%919K
-22.54%1.26M
-36.50%1.09M
49.22%8.02M
23.30%3.36M
23.72%1.33M
81.66%1.62M
148.99%1.72M
Research and development costs
-9.32%8.27M
-15.82%1.88M
-1.65%2.2M
-7.80%2.08M
-11.82%2.11M
55.23%9.12M
39.73%2.24M
44.70%2.24M
42.18%2.26M
109.27%2.39M
Operating profit
6.95%-15.58M
13.15%-3.42M
-0.54%-4.12M
4.67%-4.08M
10.58%-3.96M
-72.14%-16.74M
-25.70%-3.93M
-43.89%-4.1M
-67.69%-4.28M
-270.91%-4.43M
Net non-operating interest income expense
486.61%924K
2,200.00%420K
186.05%123K
180.00%192K
959.09%189K
-39.77%-239K
37.50%-20K
213.16%43K
-411.69%-240K
87.64%-22K
Total other finance cost
-486.61%-924K
-2,200.00%-420K
-186.05%-123K
-180.00%-192K
-959.09%-189K
39.77%239K
--20K
---43K
--240K
--22K
Other net income (expense)
Income before tax
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
-224.36%-4.45M
Income tax
Net income
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
-224.36%-4.45M
Net income continuous Operations
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
-224.36%-4.45M
Minority interest income
Net income attributable to the parent company
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
-224.36%-4.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
-82.59%-4.52M
-224.36%-4.45M
Basic earnings per share
30.43%-0.32
38.68%-0.065
20.91%-0.087
29.03%-0.088
33.33%-0.08
-31.43%-0.46
-4.95%-0.106
-18.28%-0.11
-44.19%-0.124
-71.43%-0.12
Diluted earnings per share
30.43%-0.32
38.68%-0.065
20.91%-0.087
29.03%-0.088
33.33%-0.08
-31.43%-0.46
-4.95%-0.106
-18.28%-0.11
-44.19%-0.124
-71.43%-0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 4.67%3.23M33.65%1.26M-48.42%327K22.48%937K-4.95%710K-25.45%3.09M-32.15%939K-6.90%634K20.09%765K-47.98%747K
Operating revenue 4.67%3.23M33.65%1.26M-48.42%327K22.48%937K-4.95%710K-25.45%3.09M-32.15%939K-6.90%634K20.09%765K-47.98%747K
Cost of revenue 17.62%1.93M43.51%686K-25.21%350K32.02%503K24.60%390K-15.59%1.64M-35.49%478K45.34%468K-0.52%381K-37.02%313K
Gross profit -10.03%1.3M23.43%569K-113.86%-23K13.02%434K-26.27%320K-34.17%1.45M-28.30%461K-53.76%166K51.18%384K-53.78%434K
Operating expense -7.19%16.88M-9.31%3.98M-3.91%4.1M-3.22%4.52M-11.98%4.28M52.56%18.18M16.49%4.39M32.97%4.27M66.19%4.67M127.91%4.86M
Selling and administrative expenses -5.05%8.6M-2.55%2.1M-6.40%1.9M1.08%2.44M-12.13%2.17M49.97%9.06M-0.65%2.16M22.07%2.03M97.38%2.41M149.49%2.47M
-Selling and marketing expense 16.55%1.21M-68.72%-2.02M39.15%981K49.87%1.18M43.91%1.08M56.01%1.04M-117.60%-1.2M19.09%705K140.37%786K150.67%747K
-General and administrative expense -7.85%7.39M22.92%4.12M-30.64%919K-22.54%1.26M-36.50%1.09M49.22%8.02M23.30%3.36M23.72%1.33M81.66%1.62M148.99%1.72M
Research and development costs -9.32%8.27M-15.82%1.88M-1.65%2.2M-7.80%2.08M-11.82%2.11M55.23%9.12M39.73%2.24M44.70%2.24M42.18%2.26M109.27%2.39M
Operating profit 6.95%-15.58M13.15%-3.42M-0.54%-4.12M4.67%-4.08M10.58%-3.96M-72.14%-16.74M-25.70%-3.93M-43.89%-4.1M-67.69%-4.28M-270.91%-4.43M
Net non-operating interest income expense 486.61%924K2,200.00%420K186.05%123K180.00%192K959.09%189K-39.77%-239K37.50%-20K213.16%43K-411.69%-240K87.64%-22K
Total other finance cost -486.61%-924K-2,200.00%-420K-186.05%-123K-180.00%-192K-959.09%-189K39.77%239K--20K---43K--240K--22K
Other net income (expense)
Income before tax 13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M-224.36%-4.45M
Income tax
Net income 13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M-224.36%-4.45M
Net income continuous Operations 13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M-224.36%-4.45M
Minority interest income
Net income attributable to the parent company 13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M-224.36%-4.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M-82.59%-4.52M-224.36%-4.45M
Basic earnings per share 30.43%-0.3238.68%-0.06520.91%-0.08729.03%-0.08833.33%-0.08-31.43%-0.46-4.95%-0.106-18.28%-0.11-44.19%-0.124-71.43%-0.12
Diluted earnings per share 30.43%-0.3238.68%-0.06520.91%-0.08729.03%-0.08833.33%-0.08-31.43%-0.46-4.95%-0.106-18.28%-0.11-44.19%-0.124-71.43%-0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg